Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its impact on patients with ...
QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, patients received the agent via subcutaneous injection every three weeks ...
According to the data on some 990,000 people diagnosed with cancer in 2016 across the country, prostate cancer logged the ...
The health ministry has released for the first time five-year survival rates for new cancer patients by cancer site that are based on data from Japan's national registry. According to the data on some ...
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
Trained immunity provides a unifying framework linking innate immune memory to both protective and maladaptive inflammation across neurological diseases, offering new insights into disease mechanisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback